Srp-9001-303
ClinicalTrials.gov NCT05881408
Research payments
$4,057,511
Through program year 2025, $4,057,511 in research payments was reported against Srp-9001-303, across 2,054 payments, paid by Sarepta Therapeutics, Inc..
- Paid by
- Sarepta Therapeutics, Inc.
- ClinicalTrials.gov
- NCT05881408
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $2,448,145 | 924 |
| 2024 | Research | $1,573,835 | 1,078 |
| 2023 | Research | $35,532 | 52 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Carmen Leon Astudillo Gainesville, FL Named on 337 payments
- Aravindhan Veerapandiyan Little Rock, AR Named on 258 payments
- Crystal Proud Norfolk, VA Named on 246 payments
- Emma Ciafaloni Rochester, NY Named on 224 payments
- Craig McDonald Sacramento, CA Named on 175 payments
- Ana Tesi Rocha Palo Alto, CA Named on 145 payments
- Amy Waldman Philadelphia, PA Named on 140 payments
- Mai El Mallah Durham, NC Named on 80 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.